LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 3.44%2.01B | 25.16%582M | -3.35%664M | -9.27%421M | 4.85%346M | 15.76%1.95B | -3.53%465M | 2.38%687M | 39.34%464M | 69.23%330M |
Net income from continuing operations | 33.71%1.54B | 236.67%505M | -9.23%344M | 2.18%422M | 28.23%268M | -8.43%1.15B | -54.95%150M | 9.54%379M | 12.53%413M | -0.95%209M |
Operating gains losses | -93.52%7M | ---- | ---- | -83.33%1M | -106.52%-6M | 2,260.00%108M | 400.00%3M | --7M | 175.00%6M | 2,200.00%92M |
Depreciation and amortization | -0.68%146M | 18.18%39M | -7.50%37M | -8.11%34M | -2.70%36M | -9.26%147M | -15.38%33M | 2.56%40M | -7.50%37M | -15.91%37M |
Deferred tax | 6.44%-247M | 4.42%-216M | 162.50%5M | 40.00%-6M | -50.00%-30M | -876.47%-264M | -1,030.00%-226M | -114.04%-8M | ---10M | -566.67%-20M |
Other non cash items | 60.42%-112M | 58.94%-62M | 114.29%2M | -17.39%-27M | 73.68%-25M | -162.04%-283M | -101.33%-151M | -40.00%-14M | -43.75%-23M | -1,257.14%-95M |
Change In working capital | -42.73%504M | -53.09%273M | -3.40%227M | -427.27%-58M | -16.22%62M | 391.62%880M | 242.35%582M | 19.29%235M | 88.66%-11M | 181.32%74M |
-Change in receivables | 18.25%-103M | ---- | ---- | ---- | ---- | 53.33%-126M | ---- | ---- | ---- | ---- |
-Change in prepaid assets | -148.15%-67M | ---- | ---- | ---- | ---- | -28.57%-27M | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | -14.36%155M | ---- | ---- | ---- | ---- | -8.59%181M | ---- | ---- | ---- | ---- |
-Change in other current assets | -68.75%5M | ---- | ---- | ---- | ---- | -79.49%16M | ---- | ---- | ---- | ---- |
-Change in other current liabilities | -70.37%184M | -108.87%-37M | ---- | ---- | ---- | 3,005.00%621M | 309.55%417M | ---- | ---- | ---- |
-Change in other working capital | 53.49%330M | 164.46%320M | ---- | ---- | ---- | 23.56%215M | -68.49%121M | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 3.44%2.01B | 25.16%582M | -3.35%664M | -9.27%421M | 4.85%346M | 15.76%1.95B | -3.53%465M | 2.38%687M | 39.34%464M | 69.23%330M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -46.23%-446M | -2.60%-79M | 33.78%-49M | -321.74%-291M | 68.24%-27M | -147.97%-305M | -208.00%-77M | -1,750.00%-74M | -1.47%-69M | -226.92%-85M |
Capital expenditure reported | 19.84%-198M | -12.86%-79M | 22.95%-47M | 28.30%-38M | 46.03%-34M | -142.16%-247M | -75.00%-70M | -134.62%-61M | -140.91%-53M | -350.00%-63M |
Net business purchase and sale | -1,506.67%-241M | --0 | 72.73%-3M | -11,750.00%-237M | 50.00%-1M | 71.70%-15M | --0 | -450.00%-11M | 93.55%-2M | 90.00%-2M |
Net investment purchase and sale | 73.08%-7M | -450.00%-7M | 150.00%1M | 92.86%-1M | --0 | -132.91%-26M | -85.71%2M | -108.70%-2M | -146.67%-14M | -200.00%-12M |
Net other investing changes | ---- | ---- | --0 | ---15M | 200.00%8M | 63.83%-17M | -1,000.00%-9M | --0 | --0 | -100.00%-8M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -46.23%-446M | -2.60%-79M | 33.78%-49M | -321.74%-291M | 68.24%-27M | -147.97%-305M | -208.00%-77M | -1,750.00%-74M | -1.47%-69M | -226.92%-85M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 48.77%-1.05B | -160.47%-771M | 132.54%232M | -53.72%-744M | 143.51%238M | -15.58%-2.04B | 44.67%-296M | -29.40%-713M | 5.47%-484M | -227.54%-547M |
Net issuance payments of debt | 358.45%1.95B | -103.24%-15M | 6,262.50%986M | 0.00%-9M | 8,358.33%991M | 1,804.00%426M | 3,661.54%463M | -220.00%-16M | 25.00%-9M | -340.00%-12M |
Net common stock issuance | -23.74%-2.89B | -3.10%-766M | -7.41%-725M | -56.60%-736M | -48.00%-666M | -47.04%-2.34B | -49.20%-743M | -33.40%-675M | -1.08%-470M | -271.90%-450M |
Cash dividends paid | 5.06%-150M | 2.63%-37M | 5.13%-37M | 7.50%-37M | 4.88%-39M | -28.46%-158M | 7.32%-38M | 4.88%-39M | 2.44%-40M | ---41M |
Proceeds from stock option exercised by employees | 82.35%93M | 89.47%36M | 150.00%10M | 17.39%27M | 300.00%20M | 75.86%51M | 46.15%19M | --4M | 91.67%23M | 25.00%5M |
Net other financing activities | -128.57%-48M | 266.67%11M | -115.38%-2M | -8.33%11M | -38.78%-68M | 62.50%-21M | -25.00%3M | 1,200.00%13M | 300.00%12M | 10.91%-49M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 48.77%-1.05B | -160.47%-771M | 132.54%232M | -53.72%-744M | 143.51%238M | -15.58%-2.04B | 44.67%-296M | -29.40%-713M | 5.47%-484M | -227.54%-547M |
Net cash flow | ||||||||||
Beginning cash position | -31.96%875M | 112.45%1.66B | -9.17%802M | 45.19%1.42B | -31.96%875M | -14.95%1.29B | -42.80%779M | -29.59%883M | -35.23%978M | -14.95%1.29B |
Current changes in cash | 230.83%522M | -391.30%-268M | 947.00%847M | -589.89%-614M | 284.44%557M | -92.75%-399M | 217.95%92M | -186.21%-100M | 63.97%-89M | -15,200.00%-302M |
Effect of exchange rate changes | -75.00%-21M | -375.00%-11M | 250.00%6M | 33.33%-4M | -100.00%-12M | 36.84%-12M | 100.00%4M | 50.00%-4M | 33.33%-6M | -50.00%-6M |
End cash Position | 57.26%1.38B | 57.26%1.38B | 112.45%1.66B | -9.17%802M | 45.19%1.42B | -31.96%875M | -31.96%875M | -42.80%779M | -29.59%883M | -35.23%978M |
Free cash flow | 6.83%1.82B | 27.34%503M | -1.44%617M | -6.81%383M | 16.85%312M | 7.60%1.7B | -10.63%395M | -2.95%626M | 32.15%411M | 47.51%267M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |